Literature DB >> 17460706

JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder.

A Pardanani, T L Lasho, S Schwager, C Finke, K Hussein, R K Pruthi, A Tefferi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17460706     DOI： 10.1038/sj.leu.2404710

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis.

Authors:  Matthew Goodyer; Stephen E Langabeer; Karl Haslam; Karen Murphy
Journal:  Pathol Oncol Res       Date:  2015-10-08       Impact factor: 3.201

2.  Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms a paper from the 2010 William Beaumont hospital symposium on molecular pathology.

Authors:  Ayalew Tefferi; Pierre Noel; Curtis A Hanson
Journal:  J Mol Diagn       Date:  2011-06-30       Impact factor: 5.568

3.  Early renal arterial stent thrombosis associated with the JAK2 V617F mutation.

Authors:  Piotr Tabaczewski; Suhasini Nadesan; Seah H Lim
Journal:  Leuk Res       Date:  2008-07-18       Impact factor: 3.156

4.  Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg.

Authors:  Mandy N Lauw; Erik W N Bus; Alexander F Y van Wulfften Palthe; Michiel Coppens; Christa H Homburg; Saskia Middeldorp; C Ellen van der Schoot; Harry R Koene; Bart J Biemond
Journal:  Ann Hematol       Date:  2011-04-12       Impact factor: 3.673
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.